CVAC Aspiration System
Calyxo, Inc. · Decision date Sep 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 15, 2026 for K261447, the CVAC® Aspiration System submitted by Calyxo, Inc. of Pleasanton, California. The device is a sterile, single-use steerable ureteral catheter with irrigation and vacuum functionality, used with the reusable CVAC Image Processor; it is classified under 21 CFR 876.1500, Class II, product code FGB, in the Gastroenterology/Urology panel. A 510(k) clearance is not a PMA approval.
The submission identifies the predicate as the CVAC Aspiration System within the CVAC Set cleared under K233472, with the CVAC Image Processor (K260013) as reference device. The summary describes changes to the passive-mode outflow path and handle component geometry, labeled CVAC 2.1, while dimensions, navigation, camera tip, accessories, single-use status, EtO sterilization and one-year shelf life are listed as unchanged. Software, cybersecurity, sterilization, shelf life, electrical safety and EMC data were leveraged. The record does not include clinical outcome data, and the public page lists a May 1, 2026 receipt date while the summary letter states August 21, 2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261447
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Calyxo, Inc.
- Product code
- FGB
- Decision code
- SESE
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ureteroscope And Accessories, Flexible/Rigid.
- Applicant
- Calyxo, Inc.
- Product code
- FGB
- FDA device class
- 2
FDA decision timeline
K261447 received
Application receipt date recorded by FDA.
K261447 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FGB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zhejiang Geyi Medical Instrument Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Vein 360 | 510(k) clearance | Oct 20, 2026 | FDA | |
| Guangzhou Red Pine Medical Instrument Co., Ltd. | 510(k) clearance | Sep 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Calyxo, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Pleasanton, CA
Sources and methodology
- Original FDA record: K261447
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

